SAM
ONC

Sabadell Asset Management’s BeOne Medicines Ltd ONC Stock Holding History

Sabadell Asset Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-3,081
Closed -$1.06M – 171
2021
Q2 		$1.06M Buy
+3,081
New +$1.02M 0.18% 108

Other funds holding ONC

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CII
Capital International Inc Los Angeles, California $13B AUM 31.88% 1-Year Est. Return

Sabadell Asset Management's ONC Position: Q3 2021 in Review

Sabadell Asset Management sold out of BeOne Medicines Ltd (ONC) in Q3 2021, closing a stake of 3,081 shares — an estimated $1.06M sold.

Sabadell Asset Management first reported a position in ONC in Q2 2021 and held it in 1 quarter. The position peaked at $1.06M in Q2 2021. 253 funds tracked by Wall St. Rank hold ONC as of Q3 2021.

  • Sabadell Asset Management reported no remaining BeOne Medicines Ltd position as of Q3 2021 after selling out during the quarter.
  • Sabadell Asset Management sold 3,081 BeOne Medicines Ltd shares in Q3 2021, an estimated $1.06M.
  • Sabadell Asset Management first reported a position in BeOne Medicines Ltd in Q2 2021 and held it in 1 quarter.
  • Sabadell Asset Management's BeOne Medicines Ltd position peaked at $1.06M in Q2 2021.
  • 253 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2021.

Based on Sabadell Asset Management's 13F filing for Q3 2021, filed 23 Jan 2024.